Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease.
Hoeper
M M
MM
Department of Pulmonary Medicine, Hannover Medical School, Germany. KMHoeper@AOL.com
Eschenbruch
C
C
Zink-Wohlfart
C
C
Schulz
A
A
Markworth
S
S
Pohl
K
K
Fabel
H
H
D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D009102:Multiple Organ Failure; D009569:Nitric Oxide / Q000008:administration & dosage* / Q000627:therapeutic use; D011668:Pulmonary Veno-Occlusive Disease / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use
D000336:Aerosols; D014665:Vasodilator Agents; D009569:Nitric Oxide; D016285:Iloprost